Moneycontrol PRO
HomeNewsEconomyPolicyHealth ministry raises alarm on monkeypox as Kerala reports first suspected case

Health ministry raises alarm on monkeypox as Kerala reports first suspected case

The letter to the states comes on a day, samples were sent out to the National Institute of Virology, Pune from a suspected patient in Kerala

July 14, 2022 / 16:49 IST
Monkeypox causes fevers and skin lesions.

The Union Health Ministry, on July 14, asked states to step up surveillance on monkeypox disease which has raised alarm worldwide over the past several weeks.

The development comes on a day a suspected case of the disease was detected in Kerala, according to authorities. The samples from the suspected patient, who is a returnee from the United Arab Emirates, have been sent to the National Institute of Virology, Pune, under the Indian Council for Medical Research (ICMR).

According to the WHO,  between January 1 and June 22 this year, a total of 3413 laboratory-confirmed cases of monkeypox and one death have been reported from 50 countries. Most of the cases recorded globally during the ongoing outbreak were among homosexual men.

In his letter to the state health secretaries, Union Health Secretary Rajesh Bhushan reiterated that there should be a rigorous surveillance system at all points of entry to quickly identify and isolate suspected cases.

It noted that the majority of the cases reported globally during the current outbreak have been recorded in the European Region (86 percent) and the Americas (11 percent).

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

“This points to a slow but sustained increase in the spread of monkeypox cases globally. Considering this is the first time that cases and clusters are being reported concurrently in five World Health Organization regions,” said the letter.

The World Health Organization has assessed the overall risk of spread of cases as "moderate" at a global level, according to the communique sent to the states.

The Centre has said that orientation and regular re-orientation of all key stakeholders including health screening teams at points of entry, disease surveillance teams, doctors working in hospitals about common signs and symptoms, differential diagnosis, case definitions for suspects, probable or confirmed cases should be carried out.

Continued expansion of the spread of monkeypox disease globally calls for proactive strengthening and operationalization of requisite public health actions for preparedness and response against the disease in India too, said the Union government.

It has asked states to screen and test all suspect cases either through hospital-based surveillance or targeted surveillance under measles surveillance or intervention sites identified by the National AIDS Control Organization for  MSM (men having sex with men) and FSW ( female sex worker) population groups.

Bhushan also wrote in his letter that patient isolation (until all lesions have resolved and scabs have completely fallen off), protection of ulcers, symptomatic and supportive therapies, continued monitoring and timely treatment of complications remain the key measures to prevent mortality.

Intensive risk communication directed at healthcare workers, identified sites in health facilities (such as skin, paediatric OPDS, immunization clinics, intervention sites. identified by NACO, etc.) as well as the general public about simple preventive strategies and the need for prompt reporting of cases needs to be undertaken, he underlined.

According to the letter, hospitals must be identified and adequate human resource and logistic support should be ensured at identified hospitals equipped to manage suspect or confirmed cases of the disease.

“As the COVID-19 pandemic continues to pose challenges, it is vital we remain aware and alert about other public health threats and proactively prepare ourselves to tackle them,” Bhushan added.

Sumi Sukanya Dutta
Sumi Sukanya Dutta
first published: Jul 14, 2022 04:16 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
CloseOutskill Genai